Vifor Pharma AG 보도자료 - 뉴스와이어

기업 뉴스룸

Vifor Pharma AG

제약, 바이오테크

스위스증권거래소 (VIFN)

GALLEN, Switzerland

Vifor Pharma AG 보도자료

3개

RSS 이메일

2022년 10월 20일 16:25

Approval of extension of exemptions from SIX disclosure and publicity obligations

Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma AG (Vifor) announced today that by decision dated October 19, 2022, SIX Exchange Regulation AG (SER) has approved an extension of the various exemptions from certain discl

건강 제약 바이오테크 사업계획

2022년 10월 12일 17:20

Approval of delisting of Vifor Pharma AG's registered shares

Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma AG (SWX:VIFN) (Vifor) announced today that Vifor has received approval for the delisting of the totality of Vifor's registered shares. On August 18, Vifor applied to SI

건강 제약 바이오테크 사업계획

2022년 8월 2일 17:05

Finalization of Vifor Pharma acquisition

Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL Limited (ASX: CSL; USOTC:CSLLY) is pleased to announce it has now received all necessary regulatory clearances for the acquisition of Vifor Pharma AG (Vifor) announced on 14 Decemb

건강 제약 바이오테크 인수/합병